Teva Pharmaceuticals USA, Inc: Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in
Read the official notice at FDA (drug) →
Get alerts for Teva Pharmaceuticals
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Teva Pharmaceuticals USA, Inc
- Product
- Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
- Reason / hazard
- Subpotent drug; Clavulanate Potassium component
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Distributed in three (3) States: MS, OH, CA.
- Recall initiated
- 2025-10-13
- Code info
- Lot # 100062316, Exp Date: 01/2026
- Product quantity
- 4680 cartons
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Parsippany
- State
- NJ
- Country
- United States
- Event id
- 97795
Free daily digest + "My products" watchlist